Synthesis and antitumor activity of the 7-O-(2,6dideoxy-2-fluoro-α-L- talopyranosyl)daunomycinone derivatives modified at C-3' or C-4'

Carbohydrate Research

Volumn 307, Issue 3-4, 1998, Pages 217-232

  Takagi, Yasushi ^a   Kobayashi, Naoki ^a   Chang, Min Sun ^a   Lim, Geun Jho ^a   Tsuchiya, Tsutomu ^a  

^a 3 34 17 Ida Kawasaki 211   (Japan)

Author keywords

7 O (2,6 Dideoxy 2 fluoro Ltalopyranosyl)daunomycinone; Anthracycline glycoside; Antitumor activity; Multidrug resistance

Indexed keywords

7 O (2,6 DIDEOXY 2 FLUORO ALPHA LEVO TALOPYRANOSYL)DAUNOMYCINONE; ANTHRACYCLINE DERIVATIVE; DAUNOMYCINONE; DAUNOMYCINONE DERIVATIVE; DOXORUBICIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CHEMICAL MODIFICATION; DRUG SYNTHESIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; LEUKEMIA L1210; LEUKEMIA P388; MICE; NEOPLASM TRANSPLANTATION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032004174     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6215(98)00026-3     Document Type: Article

References (43)

1. Reviews: (a) F. Arcamone, The Development of New Antitumour Anthracyclines, in J.M. Cassady and J.D. Douros (Eds.) Anticancer Agents Based on Natural Product Models, Academic Press, New York, 1980, pp 1-41;
2. (b) F. Arcamone, Doxorubicin, Academic Press, New York, 1981;
3. (c) H.S. El Khadem (Ed.), Anthracycline Antibiotics, Academic Press, New York, 1982;
4. (d) J.W. Lown (Ed.), Anthracycline and Anthracenedione-Based Anticancer Agents, Elsevier, Amsterdam, 1988;
5. (e) A. Suarato, F. Angelucci and A. Bargiotti, Chimicaoggi, 8 (1990) 9-19;
6. (f) W. Priebe (Ed.), Anthracycline Antibiotics, ACS Symposium Series. 574, Am. Chem. Soc., Washington, DC, 1995.
7. (a) Igarashi J. and Sunagawa M., Bioorg. Med. Chem. Lett., 5 (1995) 2923-2928;
8. (b) N. Aligiannis, N. Pouli, P. Marakos, A.-L. Skaltsounis, S. Leonce, A. Pierre, and G. Atassi, Bioorg. Med. Chem. Lett., 6 (1996) 2473-2476;
9. (c) F. Kratz, U. Beyer, P. Schumacher, M. Krüger, H. Zahn, T. Roth, H.H. Fiebig, and C. Unger, Bioorg. Med. Chem. Lett., 7 (1997) 617-622;
10. (d) T. Kunnari, J. Niemi, K. Ylihonko, P. Mäntsälä, and J. Hakala, Bioorg. Med. Chem. Lett., 7 (1997) 725-726;
11. (e) B.A. Schweitzer and T.H. Koch, J. Am. Chem. Soc., 115 (1993) 5440-5445;
12. (f) A. Cherif and D. Farquhar, J. Med. Chem., 35 (1992) 3208-3214;
13. (g) V.M. Vrudhula, H.P. Svensson, and P.D. Senter, J. Med. Chem., 38 (1995) 1380-1385;
14. (h) J.B. Chaires, F. Leng, T. Przewloka, I. Fokt, Y.-H. Ling, R. Perez-Solar, and W. Priebe, J. Med. Chem., 40 (1997) 261-266;
15. (i) G. Capranico, R. Supino, M. Binaschi, L. Capolongo, M. Grandi, A. Suarato, and F. Zunino, Mol. Pharmacol., 45 (1994) 908-915;
16. (j) A. Nagy, P. Armatis, and A.V. Schally, Proc. Natl. Acad. Sci. USA, 93 (1996) 2464-2469;
17. (k) F. Pasqui, F. Canfarini, A. Giolitti, A. Guidi, V. Pestellini, and F. Arcamone, Tetrahedron, 52 (1996) 185-198;
18. (l) S. Castillon, A. Dessinges, R. Faghih, G. Lukacs, A. Olesker, and T.T. Thang, J. Org. Chem., 50 (1985) 4913-4917;
19. (m) H.H. Baer and L. Siemsen, Can. J. Chem., 66 (1988) 187-190;
20. (n) Y. Takagi, H. Park, T. Tsuchiya, S. Umezawa, T. Takeuchi, K. Komuro, and C. Nosaka, J. Antibiot., 42 (1989) 1315-1317;
21. (o) H.H. Baer and F. Hernández Mateo, Can. J. Chem., 68 (1990) 2055-2059.
22. T. Tsuchiya, Y. Takagi, K. Ok, S. Umezawa, T. Takeuchi, N. Wako, and H. Umezawa, J. Antibiot., 39 (1986) 731-733.
23. K. Ok, Y. Takagi, T. Tsuchiya, S. Umezawa, and H. Umezawa, Carbohydr. Res., 169 (1987) 69-81.
24. (a) E.-F. Fuchs, D. Horton, and W. Weckerle, Carbohydr. Res., 57 (1977) C36-C39;
25. (b) D. Horton, W. Priebe, and O. Varela, J. Antibiot., 37 (1984) 853-858.
26. (a) M.-N. Borrel, M. Fiallo, W. Priebe, and A. Garnier-Suillerot, FEBS Lett., 356 (1994) 287-290;
27. (b) L. Lothstein, T.W. Sweatman, and W. Priebe, Bioorg. Med. Chem. Lett., 5 (1995) 1807-1812.
28. T. Tsuchiya, Y. Takagi, S. Umezawa, T. Takeuchi, K. Komuro, C. Nosaka, H. Umezawa, S. Fukatsu, and T. Yoneta, J. Antibiot., 41 (1988) 988-991.
29. T. Tsuruo, K. Yusa, Y. Sudo, R. Takamori, and Y. Sugimoto, Cancer Res., 49 (1989) 5537-5542.
30. J.A. Endicott and V. Ling, Annu. Rev. Biochem., 58 (1989) 137-171.
31. A.B. Shapiro and V. Ling, J. Biol. Chem., 270 (1995) 16167-16175.
32. T. Tsuruo, H. Ida, H. Kawabata, S. Tsukagoshi, and Y. Sakurai, Cancer Res., 44 (1984) 5095-5099.
33. E. Pereira, E. Teodori, S. Dei, F. Gualtieri, and A. Garnier-Suillerot, Biochem. Pharmacol., 50 (1995) 451-457.
34. T. Tsuruo, H. Ida, S. Tsukagoshi, and Y. Sakurai, Cancer Res., 42 (1982) 4730-4733.
35. M. Bakker, W.T.A. van der Graaf, H.J.M. Groen, E.F. Smit, and E.G.E. De Vries, Curr. Pharm. Des., 1 (1995) 133-144.
36. H.S. Mülder, H. Dekker, H.M. Pinedo, and J. Lankelma, Biochem. Pharmacol., 50 (1995) 967-974.
37. Brief summary: (a) Y. Takagi, T. Tsuchiya, T. Miyake, T. Takeuchi, and S. Umezawa, J. Synthetic Org. Chem., Jpn., 50 (1992) 131-142;
38. (b) T. Tsuchiya and Y. Takagi, Synthesis and Biological Activities of Florinated Daunorubicin and Doxorubicin Analogues, in W. Priebe (Ed.), Anthracycline Antibiotics, ACS Symposium Series 547, Am. Chem. Soc., Washington DC, 1995. pp 100-114.
39. Y. Kimura, M. Suzuki, T. Matsumoto, R. Abe, and S. Terashima, Bull. Chem. Soc. Jpn, 59 (1986) 423-431.
40. F. Arcamone, L. Bernardi, P. Giardino, and A. Di Marco, Ger. offen. 2.652, 391, May 26, 1977; Chem. Abstr., 87 (1977) 152, 522f.
41. F. Arcamone, L. Bernardi, P. Giardino, and A. Di Marco, Ger. offen. 2.652, 391, May 26, 1977; Chem. Abstr., 87 (1977) 152, 522f.
42. W. J. Middleton, Org. Synth., 64 (1985) 221-225.
43. A. Maeda, K. Yazawa, Y. Mikami, M. Ishibashi, and J. Kobayashi, J. Antibiot., 45 (1992) 1848-1852.